help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Staal, A.
Right arrow Articles by Stein, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Staal, A.
Right arrow Articles by Stein, J. L.

Molecular Endocrinology, Vol 10, 1444-1456, Copyright © 1996 by Endocrine Society


ARTICLES

Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D- responsive elements of the osteocalcin and osteopontin genes

A Staal, AJ van Wijnen, JC Birkenhager, HA Pols, J Prahl, H DeLuca, MP Gaub, JB Lian, GS Stein, JP van Leeuwen and JL Stein
Department of Internal Medicine III, Erasmus University Medical School, Rotterdam, The Netherlands.

The 1 alpha,25-dihydroxyvitamin D3 (VD3)-dependent stimulation of osteocalcin (OC) and osteopontin (OP) gene transcription in bone tissue is mediated by interactions of trans-activating factors with distinct VD3-responsive elements (VDREs). Sequence variation between the OC- and OP-VDRE steroid hormone half-elements provides the potential for recognition by distinct hormone receptor homo- and heterodimers. However, the exact composition of endogenous VD3- induced complexes recognizing the OC- and OP-VDREs in osteoblasts has not been definitively established. To determine the identity of these complexes, we performed gel shift immunoassays with nuclear proteins from ROS 17/ 2.8 osteoblastic cells using a panel of monoclonal antibodies. We show that VD3- inducible complexes interacting with the OC- and OP-VDREs represent two distinct heterodimeric complexes, each composed of the vitamin D receptor (VDR) and the retinoid X receptor-alpha (RXR). The OC- and OP-VDR/RXR alpha heterodimers are immunoreactive with RXR antibodies and several antibodies directed against the ligand-binding domain of the VDR. However, while the OC-VDRE complex is also efficiently recognized by specific monoclonal antibodies contacting epitopes in or near the VDR DNA-binding domain (DBD) (between amino acids 57-164), the OP-VDRE complex is not efficiently recognized by these antibodies. By systematically introducing a series of point- mutations in the OC-VDRE, we find that two internal nucleotides of the proximal OC-VDRE half-site (nucleotide -449 and -448; 5'-AGGACA) determine differences in VDR immunoreactivity. These results are consistent with the well established polarity of RXR heterodimer binding to bipartite hormone response elements, with the VDR recognizing the 3'-half-element. Furthermore, our data suggest that the DBD of the VDR adopts different protein conformations when contacting distinct VDREs. Distinctions between the OC- and OP-VDR/RXR alpha complexes may reflect specialized requirements for VD3 regulation of OC and OP gene expression in response to physiological cues mediating osteoblast differentiation.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Zhou, R. S. Heist, G. Liu, D. S. Neuberg, K. Asomaning, L. Su, J. C. Wain, T. J. Lynch, E. Giovannucci, and D. C. Christiani
Polymorphisms of Vitamin D Receptor and Survival in Early-Stage Non-Small Cell Lung Cancer Patients.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2239 - 2245.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. A. Fretz, L. A. Zella, S. Kim, N. K. Shevde, and J. W. Pike
1,25-Dihydroxyvitamin D3 Regulates the Expression of Low-Density Lipoprotein Receptor-Related Protein 5 via Deoxyribonucleic Acid Sequence Elements Located Downstream of the Start Site of Transcription
Mol. Endocrinol., September 1, 2006; 20(9): 2215 - 2230.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Paredes, G. Arriagada, F. Cruzat, A. Villagra, J. Olate, K. Zaidi, A. van Wijnen, J. B. Lian, G. S. Stein, J. L. Stein, et al.
Bone-Specific Transcription Factor Runx2 Interacts with the 1{alpha},25-Dihydroxyvitamin D3 Receptor To Up-Regulate Rat Osteocalcin Gene Expression in Osteoblastic Cells
Mol. Cell. Biol., October 15, 2004; 24(20): 8847 - 8861.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Coppola, M. Szabo, D. Boulware, P. Muraca, M. Alsarraj, A. F. Chambers, and T. J. Yeatman
Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumor Histologies
Clin. Cancer Res., January 1, 2004; 10(1): 184 - 190.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Ramirez-Carrozzi and T. Kerppola
Asymmetric Recognition of Nonconsensus AP-1 Sites by Fos-Jun and Jun-Jun Influences Transcriptional Cooperativity with NFAT1
Mol. Cell. Biol., March 1, 2003; 23(5): 1737 - 1749.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Shen, M. Montecino, J. B. Lian, G. S. Stein, A. J. van Wijnen, and J. L. Stein
Histone Acetylation in Vivo at the Osteocalcin Locus Is Functionally Linked to Vitamin D-dependent, Bone Tissue-specific Transcription
J. Biol. Chem., May 31, 2002; 277(23): 20284 - 20292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G.-J. C. M. van den Bemd, M. Jhamai, A. Staal, A. J. van Wijnen, J. B. Lian, G. S. Stein, H. A. P. Pols, and J. P. T. M. van Leeuwen
A Central Dinucleotide within Vitamin D Response Elements Modulates DNA Binding and Transactivation by the Vitamin D Receptor in Cellular Response to Natural and Synthetic Ligands
J. Biol. Chem., April 19, 2002; 277(17): 14539 - 14546.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. R. Wood, V. S. Likhite, M. A. Loven, and A. M. Nardulli
Allosteric Modulation of Estrogen Receptor Conformation by Different Estrogen Response Elements
Mol. Endocrinol., July 1, 2001; 15(7): 1114 - 1126.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. J. Koszewski, S. Ashok, and J. Russell
Turning a Negative into a Positive: Vitamin D Receptor Interactions with the Avian Parathyroid Hormone Response Element
Mol. Endocrinol., March 1, 1999; 13(3): 455 - 465.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
F. Aslam, L. McCabe, B. Frenkel, A. J. van Wijnen, G. S. Stein, J. B. Lian, and J. L. Stein
AP-1 and Vitamin D Receptor (VDR) Signaling Pathways Converge at the Rat Osteocalcin VDR Element: Requirement for the Internal Activating Protein-1 Site for Vitamin D-Mediated Trans-Activation
Endocrinology, January 1, 1999; 140(1): 63 - 70.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
J. R. Wood, G. L. Greene, and A. M. Nardulli
Estrogen Response Elements Function as Allosteric Modulators of Estrogen Receptor Conformation
Mol. Cell. Biol., April 1, 1998; 18(4): 1927 - 1934.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. Takeuchi, G. S. Reddy, T. Kobayashi, T. Okano, J. Park, and S. Sharma
Nuclear Factor of Activated T Cells (NFAT) as a Molecular Target for 1{alpha},25-Dihydroxyvitamin D3-Mediated Effects
J. Immunol., January 1, 1998; 160(1): 209 - 218.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Guo, F. Aslam, A. J. van Wijnen, S. G. E. Roberts, B. Frenkel, M. R. Green, H. DeLuca, J. B. Lian, G. S. Stein, and J. L. Stein
YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene
PNAS, January 7, 1997; 94(1): 121 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Chen, B. Hu, E. A. Allegretto, and J. S. Adams
The Vitamin D Response Element-binding Protein. A NOVEL DOMINANT-NEGATIVE REGULATOR OF VITAMIN D-DIRECTED TRANSACTIVATION
J. Biol. Chem., November 3, 2000; 275(45): 35557 - 35564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society